Table 1.
Mutants | Viabilitya | Fertilityb | DNA-damage sensitivityc | Gene-silencing defectsd | ||
---|---|---|---|---|---|---|
♂ | ♀ | UV | X-Ray | |||
H3T3A | ++ | ++ | sterile | + | +++ | + |
H3T11A | + | + | sterile | nt | nt | - |
H3R17A | ++ | + | sterile | nt | nt | - |
H3K18A | +++ | ++ | ++ | ++ | ++ | - |
H3K23A | ++ | ++ | + | + | + | +++ |
H3K56A | ++ | ++ | sterile | +++ | +++ | +++ |
H3K64A | +++ | ++ | ++ | + | + | - |
H3T107A | ++ | ++ | + | + | +++ | - |
H3K115A | +++ | +++ | ++ | + | +++ | - |
H3K122A | +++ | ++ | ++ | + | +++ | - |
H4T1A | ++ | ++ | ++ | + | +++ | ++ |
H4R3A | +++ | ++ | + | + | ++ | - |
H4K5A | +++ | ++ | +++ | + | + | - |
H4K8A | ++ | +++ | +++ | ++ | ++ | - |
H4K16A | ++* | ++ | + | + | +++ | - |
H4K20A | + | nt | nt | nt | nt | - |
H4R23A | ++ | +++ | + | + | +++ | +++ |
H4K31A | +++ | ++ | ++ | + | ++ | + |
H4Y51A | ++ | ++ | +++ | + | ++ | - |
H4K77A | +++ | +++ | ++ | ++ | ++ | - |
H4R92A | +++ | ++ | + | + | ++ | + |
Lethal stage | Mutants | |||||
Embryo | H3K4A, H3K14A, H3R26A, H3K27A, H3Y41A, H3T80A, H4Y88A, H4K91A | |||||
Larva | H3K9A, H3T45A, H3K37A | |||||
Pupa | H3R2A, H3T6A, H3R8A, H3S10A, H3S28A, H3K36A, H3K79A, H4K12A |
Viability was represented by the rescue ratios of mutants, which was calculated as the following: ratio = (number of homozygous adult progenies)/(one-third of the number of total adult progenies) × 100. +++ >80%; ++ 30%–80%; + ≤30%.
Fertility was represented by the number of progeny of mutants when crossing with a wild-type counterpart. +++ >80; ++ 30–80; + ≤30; nt not tested.
DNA damage sensitivity was represented by the eclosion ratio, which was calculated as the following: ratio = [E (eclosed pharate number in UV or X-ray group)]/[C (eclosed pharate number in control group)] × 100. Third instar larvae were treated with 100 J/cm2 of UV or 30 Gy of X-ray irradiation. +++ <50%; ++ 50–75%; + ≥75%; nt not tested.
Gene silencing was measured by RT-PCR with primers specific to copia retrotransposon. – no changes compared with wild type. + Low expression; ++ Medium expression; +++ Strong expression.
Limited male (<1/1000 viable).
See also Figure S5.